Security key
00654J206
Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN)
CUSIP: 00654J206
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / American Depositary Shares, each representing 120 ordinary shares Ordinary shares
- Total 13F shares
- 141
- Total 13F value
- $389
- Share change
- +140
- SEC-reported price per share
- $2.76
- Number of holders
- 1
- Value change
- +$386
- Number of buys
- 1
- Shares outstanding
- 212,716,027
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
1
Top holders
1
ADXN full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
Addex Therapeutics Ltd. SEC filings
Addex Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00654J206
Recent filing periods:
Ownership snapshot
Top reported holders of ADXN - Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Timothy Mark Dyer
Disclosed value leader
Timothy Mark Dyer
Comparable rows
1/10
Latest evidence
02 Sep 2026
13D/G
3/4/5
13F
Lead comparable stake: 9%
9 rows are not safely comparable across share classes.
13D/G row: Timothy Mark Dyer
Showing 1-6 of 10 holder rows.
Quick read
Timothy Mark Dyer leads the comparable SEC ownership view at 9%.
1 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Timothy Mark Dyer's linked filing trail.
Comparable ownership
Top 1
Timothy Mark Dyer
9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Timothy Mark Dyer |
13D/G
3/4/5
CHIEF EXECUTIVE OFFICER, Director
|
9%
Reported 13D/G
· 02 Sep 2026
|
$112,140,509
19,165,714 shares
|
+$410,771 | 02 Sep 2026 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$268
47 shares
|
— | 30 Jun 2026 |
| SBI Securities Co., Ltd. |
13F
Company
|
—
denominator unverified
|
$6
1 shares
|
— | 30 Jun 2026 |
| Vincent Michael Lawton |
3/4/5
Director
|
—
mixed-class rows
|
—
3,009,585 shares
mixed-class rows
|
— | 02 Sep 2026 |
| Raymond George Hill |
3/4/5
Director
|
—
mixed-class rows
|
—
1,638,639 shares
mixed-class rows
|
— | 02 Sep 2026 |
| Roger Mills |
3/4/5
CHIEF MEDICAL OFFICER, Director
|
—
mixed-class rows
|
—
835,976 shares
mixed-class rows
|
— | 02 Sep 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
141
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
2
Q3 2026 holders
1
Holder diff
-1
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend